Overview

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
Evaluate the behavioral effects of MTS in children aged 6-12 with ADHD
Phase:
Phase 2
Details
Lead Sponsor:
Noven Therapeutics
Treatments:
Methylphenidate